SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.

Anft, Moritz; Paniskaki, Krystallenia; Giglio, Tina; Wellenkötter, Jacqueline; Blazquez-Navarro, Arturo; Meister, Toni L; Roch, Toralf; Giesecke-Thiel, Claudia; Westhoff, Timm H; Stervbo, Ulrik; Pfaender, Stephanie; Cinkilic, Okan; Babel, Nina

Anft, Moritz; Paniskaki, Krystallenia; Giglio, Tina; Wellenkötter, Jacqueline; Blazquez-Navarro, Arturo; Meister, Toni L; Roch, Toralf; Giesecke-Thiel, Claudia; Westhoff, Timm H; Stervbo, Ulrik; Pfaender, Stephanie; Cinkilic, Okan; Babel, Nina.

Affiliation

Anft M; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Paniskaki K; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University Dui
Giglio T; Dialyse Schwerte, Schwerte, Germany.
Wellenkötter J; Dialyse Schwerte, Schwerte, Germany.
Blazquez-Navarro A; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology,
Meister TL; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Roch T; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology,
Giesecke-Thiel C; Max Planck Institute for Molecular Genetics, Berlin, Germany.
Westhoff TH; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Stervbo U; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.
Pfaender S; Department of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Cinkilic O; Dialyse Schwerte, Schwerte, Germany.
Babel N; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany; Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, and Institute of Medical Immunology,

Kidney Int ; 103(1): 223-225, 2023 01.

Article de En | MEDLINE | ID: mdl-36332726

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / COVID-19 Limites: Humans Langue: En Journal: Kidney Int Année: 2023 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google